2.4 semaglutide & Muscle Loss: What GLP-1 Drugs Do Wegovy is an injectable form of semaglutide that is administered once a week using a prefilled pen injector New formula could mean diabetes

18 No similar improvement was observed in a human trial looking at depression

Wegovy, derived from semaglutide, acts as a GLP-1 receptor agonist, mimicking the GLP-1 hormone to reduce appetite by increasing insulin secretion and signaling feelings of fullness to the brain, he says

The subjects were matched with 50 controls by age, sex, diabetes duration, body mass index (BMI) and glycated haemoglobin (HbA1c)

PubMed laboratory research record [PMID: 34430539] PubMed record related to this compound for laboratory literature review

Thats why good gut health impacts not only your digestive system but all your body functions